Viewing Study NCT05482503


Ignite Creation Date: 2025-12-24 @ 7:24 PM
Ignite Modification Date: 2025-12-28 @ 12:57 AM
Study NCT ID: NCT05482503
Status: COMPLETED
Last Update Posted: 2022-08-02
First Post: 2022-07-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Clinical Investigation to Evaluate the Effectiveness and Safety of ECG App
Sponsor: Huawei Device Co., Ltd
Organization:

Study Overview

Official Title: Clinical Investigation to Evaluate the Effectiveness and Safety of ECG App
Status: COMPLETED
Status Verified Date: 2022-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to verify the effectiveness and safety of the Huawei Device software (ECG APP), which can be used to analyze, store and display the ECG data transmitted by the single-lead ECG acquisition device. The software can be used for the analysis of sinus rhythm, atrial fibrillation, and premature beats(ventricular premature beats and atrial premature beats) in adults.
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: